The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market with a full portfolio of glucagon-like peptide 1 (GLP-1) receptor agonists, modern ...

The top content from the Institute for Value-Based Medicine® (IVBM®) highlighted innovative approaches to improving care ...